The Health Insurance Fund: allowances in respect of reimbursable medicines have already dropped by half
After the new pricelist of Reimbursable medicines has become effective in the middle of July and the levels of medicine reimbursement have been increased, the patient spending on extras to be paid for medicines has dropped almost by half, i.e. by 1.8 times, already in the first month of changes. The specialists of the National Health Insurance Fund under the Ministry of Health (NHIF) have no doubt that the novelties introduced will become a significant financial support to a million patients in the country.
Calculations of the specialists of the NHIF show that it took just one month for the residents to really feel the positive changes after the introduction of novelties of medicine reimbursement. During this time allowances in respect of reimbursable medicines of almost 300 thousand patients have dropped by 44 %. It means that the residents spent 1.43 million euros less for medicines compared to the same time last year.
"This is due to several reasons: increased levels of medicine reimbursement from 80 to 90 and 100 % level, and due to the fact that as per the new pricing of reimbursable medicines an extra to be paid by the patient for a package of the most of reimbursable medicines does not exceed 4.11 euros when the medicine falls within a group of 100 % reimbursable medicines. Reimbursable medicines in Lithuania every year are used by more than one million residents. Therefore, the decisions adopted will allow significantly reduce the financial burden for a really large part of the patients", - says Neringa Bernotienė, the Depuy Director of the NHIF.
In her view, within a calendar year from the beginning of the changes made the patients could save around 17 million euros for reimbursable medicines.
The NHIF recalls that in the middle of July in order to implement the recommendations of the Organization for Economic Co-operation and Development and of the World Health Organization the levels of medicine reimbursement have been increased. The level of reimbursement of cardiovascular medicines has been increased from 80 to 90 %. Whereas the level of reimbursement of medicines intended to treat infectious and parasitic diseases, endocrine, nutritional and metabolic diseases, nervous and digestive system diseases, connective tissue and skeletal-muscular system diseases, urogenital system diseases, etc., has been increased from 80 or 90 % to 100 %. It is projected that 8.2 million euros will be additionally required for this purpose from the budget of the Compulsory Health Insurance Fund.
The NHIF notes that from the end of the existence of 80 % level of medicine reimbursement, there must remain no such prescriptions of reimbursable medicines in pharmacies.
The NHIF invites you:
Your questions are welcome by email firstname.lastname@example.org or phone: local 8 700 88888, international +370 5 236 4114